Abstract
Low‐grade fibromyxoid sarcoma (LGFMS) is a rare neoplasm that commonly arises in the deep soft tissues of the lower extremities, particularly in the thigh. LGFMS occurs preferentially in young male adults. The microscopic appearance of LGFMS exhibits bland fibroblastic spindle cells with a whorled or linear arrangement in fibrous and myxoid areas. Although LGFMS has a deceptively benign histologic appearance, local recurrence and late metastases have frequently been reported. Diagnosis of LGFMS is still difficult because of its characteristic bland‐looking histologic features that can be confused with other benign or low‐grade fibromyxoid lesions. Although immunohistochemical staining can offer an overview of the differential diagnosis of myxoid tumors of soft tissue, it is sometimes limited for diagnosis of LGFMS. However, recent cytogenetic and molecular analyses have provided significant improvements in the diagnosis of LGFMS. Such analyses have demonstrated that most cases of LGFMS have a characteristic t (7,16) (q33;p11) translocation, resulting in the FUS‐CREB3L2 fusion gene. We report a 29‐year‐old female who presented with a LGFMS located in the soleus muscle of her left lower leg. Preoperative imaging suggested the possibility of an intramuscular histiocytoma of the left soleus muscle. In conclusion, diagnosis of LGFMS can be challenging in routine practice in surgical pathology because of its bland‐looking features. The immunohistochemical and ultrastructural findings were consistent with the fibroblastic properties of LGFMS. Cytogenetic and/or molecular genetic analyses can be used as ancillary diagnostic tools for LGFMS.
Keywords: fibromyxoid, FUS‐CREB3L2, low‐grade fibromyxoid sarcoma
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
References
- 1. Evans HL. Low‐grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987; 88: 615–619. [DOI] [PubMed] [Google Scholar]
- 2. Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low‐grade fibromyxoid sarcoma. Am J Surg Pathol. 1997; 21: 1481–1488. [DOI] [PubMed] [Google Scholar]
- 3. Evans HL. Low‐grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. 1993; 17: 595–600. [DOI] [PubMed] [Google Scholar]
- 4. Koh SH, Choe HS, Lee IJ, et al. Low‐grade fibromyxoid sarcoma: ultrasound and magnetic resonance findings in two cases. Skeletal Radiol. 2005; 34: 550–554. [DOI] [PubMed] [Google Scholar]
- 5. Folpe AL, Lane KL, Paull G, et al. Low‐grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high‐grade areas. Am J Surg Pathol. 2000; 24: 1353–1360. [DOI] [PubMed] [Google Scholar]
- 6. Goodlad JR, Mentzel T, Fletcher CD. Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology. 1995; 26: 229–237. [DOI] [PubMed] [Google Scholar]
- 7. Lindberg GM, Maitra A, Gokaslan ST, et al. Low grade fibromyxoid sarcoma: fine‐needle aspiration cytology with histologic, cytogenetic, immunohistochemical, and ultrastructural correlation. Cancer. 1999; 87: 75–82. [PubMed] [Google Scholar]
- 8. Guillou L, Benhattar J, Gengler C, et al. Translocationpositive low‐grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol. 2007; 31: 1387–1402. [DOI] [PubMed] [Google Scholar]
- 9. Antonescu CR, Baren A. Spectrum of low‐grade fibrosarcomas: a comparative ultrastructural analysis of low‐grade myxofibrosarcoma and fibromyxoid sarcoma. Ultrastruct Pathol. 2004; 28: 321–332. [DOI] [PubMed] [Google Scholar]
- 10. Bejarano PA, Padhya TA, Smith R, et al. Hyalinizing spindle cell tumor with giant rosettes—a soft tissue tumor with mesenchymal and neuroendocrine features. An immunohistochemical, ultrastructural, and cytogenetic analysis. Arch Pathol Lab Med. 2000; 124: 1179–1184. [DOI] [PubMed] [Google Scholar]
- 11. Panagopoulos I, Storlazzi CT, Fletcher CD, et al. The chimeric FUS/CREB3l2 gene is specific for low‐grade fibromyxoid sarcoma. Genes Chromosomes Cancer. 2004; 40: 218–228. [DOI] [PubMed] [Google Scholar]
- 12. Reid R, de Silva MV, Paterson L, et al. Low‐grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol. 2003; 27: 1229–1236. [DOI] [PubMed] [Google Scholar]
- 13. Bhattacharya B, Dilworth HP, Iacobuzio‐Donahue C, et al. Nuclear beta‐catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol. 2005; 29: 653–659. [DOI] [PubMed] [Google Scholar]
- 14. Ng TL, Gown AM, Barry TS, et al. Nuclear beta‐catenin in mesenchymal tumors. Mod Pathol. 2005; 18: 68–74. [DOI] [PubMed] [Google Scholar]